Publications by authors named "Jadranka Mitrovic"

Obesity is a multifactorial pathophysiological condition with an imbalance in biochemical, immunochemical, redox status and genetic parameters values. We aimed to estimate the connection between relative leucocyte telomere lengths (rLTL) - biomarker of cellular ageing with metabolic and redox status biomarkers values in a group of obese and lean children. The study includes 110 obese and 42 lean children and adolescents, both sexes.

View Article and Find Full Text PDF

BACKGROUND New renal biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) show promise in early diagnosis of contrast media induced acute kidney injury (CI-AKI). The purpose of our study was to compare the subclinical nephrotoxicity (a condition without changes in standard renal biomarkers) of gadolinium-based contrast media (Gd-DTPA, gadopentetate dimeglumine) and iodinated-based contrast media (iopromide) in pediatric patients with normal kidney function. MATERIAL AND METHODS The first group (n=58) of patients included in the study were undergoing angiography with iopromide, and the second group (n=65) were undergoing magnetic resonance (MR) angiography/urography with Gd-DTPA administration.

View Article and Find Full Text PDF

Background: Prediabetes is characterized by isolated impaired fasting glucose (IFG), isolated impaired glucose tolerance (IGT), and combined IFG/IGT. This study aimed to establish the prevalence of prediabetes and examine possible contributory factors in a cohort of obese adolescents.

Methods: In this prospective study, we recruited 85 obese patients from the Obesity Clinic at the University Children's Hospital and 17 normal weight controls.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the impact of carvedilol as an additional treatment on heart function in children with idiopathic dilated cardiomyopathy (DCM), focusing on measurements like ejection fraction and fractional shortening.
  • Children aged 16 and under with stable DCM and specific heart failure classifications participated in a year-long study comparing their health metrics before and after taking carvedilol alongside standard treatments.
  • Results indicated that some children experienced serious side effects leading to discontinuation of carvedilol, emphasizing the need for careful monitoring during treatment.
View Article and Find Full Text PDF